Cargando…

Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells

BACKGROUND: Radiation therapy is a palliative treatment modality for canine osteosarcoma, with transient improvement in analgesia observed in many cases. However there is room for improvement in outcome for these patients. It is possible that the addition of sensitizing agents may increase tumor res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantovani, Fernanda B., Morrison, Jodi A., Mutsaers, Anthony J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888507/ https://www.ncbi.nlm.nih.gov/pubmed/27245053 http://dx.doi.org/10.1186/s12917-016-0707-7

Ejemplares similares

Effects of the potassium‐sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells
por: Poon, Andrew C., et al.
Publicado: (2018)

Expression and localization of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor in the canine testis
por: TAMADA, Hiromichi, et al.
Publicado: (2015)

Epidermal Growth Factor Receptor: Is It a Feasible Target for the Treatment of Osteosarcoma?
por: Lee, Jun Ah, et al.
Publicado: (2012)

Stem cell growth factor receptor in canine vs. feline osteosarcomas
por: Wolfesberger, Birgitt, et al.
Publicado: (2016)

Epidermal growth factor receptor expression in canine transitional cell carcinoma
por: HANAZONO, Kiwamu, et al.
Publicado: (2014)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Allosteric regulation of the epidermal growth factor receptor kinase
Publicado: (1986)

Molecular Determinants of Glioblastoma Response to Epidermal Growth Factor Receptor Kinase Inhibitors
por: Komotar, Ricardo J., et al.
Publicado: (2008)

Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas
por: Veloso, Emerson Soares, et al.
Publicado: (2020)

Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells
por: Li, Dapeng, et al.
Publicado: (2018)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer
por: YOSHIMOTO, Sho, et al.
Publicado: (2020)

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?
por: Banno, Eri, et al.
Publicado: (2016)

Expression of Sex Hormone Receptors in Canine Osteosarcoma
por: Dilley, Kristyn N., et al.
Publicado: (2022)

Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors
por: Cannon, Claire M, et al.
Publicado: (2013)

Inhibiting Epidermal Growth Factor Receptor at a Distance
por: Sinclair, Julie K.-L., et al.
Publicado: (2014)

IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer
por: Wu, Shang-Gin, et al.
Publicado: (2019)

AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways
por: Yin, Wei, et al.
Publicado: (2021)

Expression of platelet-derived growth factor BB, erythropoietin and erythropoietin receptor in canine and feline osteosarcoma
por: Meyer, F.R.L., et al.
Publicado: (2015)

Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor
por: Pulit-Penaloza, Joanna A., et al.
Publicado: (2015)

Receptor-mediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells
Publicado: (1987)

Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade
por: Martin, Janet L., et al.
Publicado: (2017)

The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells
por: Schott, Courtney R., et al.
Publicado: (2018)

MAT2B promotes proliferation and inhibits apoptosis in osteosarcoma by targeting epidermal growth factor receptor and proliferating cell nuclear antigen
por: Yuan, Yuan, et al.
Publicado: (2019)

Analysis of the epidermal growth factor receptor/phosphoinositide‐dependent protein kinase‐1 axis in tumor of the external auditory canal in response to epidermal growth factor stimulation
por: Akiyama, Naotaro, et al.
Publicado: (2022)

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
por: Lim, Malcolm, et al.
Publicado: (2022)

MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma
por: Yang, Mengkai, et al.
Publicado: (2021)

Mesenchymal stem cells with rhBMP-2 inhibits the growth of canine osteosarcoma cells
por: Grassi Rici, Rose Eli, et al.
Publicado: (2012)

Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2
por: Tanaka, Hidekazu, et al.
Publicado: (2014)

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
por: Park, Sojung, et al.
Publicado: (2021)

A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma
por: Matsumura, Sosuke, et al.
Publicado: (2023)

Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
por: Bouchez, Clémentine, et al.
Publicado: (2020)

Comparison of epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) immunohistochemical expression and outcomes in canine nasal carcinomas treated with radiation therapy
por: FU, Dah-Renn, et al.
Publicado: (2022)

Estrogen Receptor β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors’ Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma
por: Zhang, Lijuan, et al.
Publicado: (2021)

Detection of human epidermal growth factor receptor 2 overexpression in canine anal sac gland carcinoma
por: YOSHIMOTO, Sho, et al.
Publicado: (2019)

Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinib
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2017)

Epidermal growth factor receptor targeting and its role for individualisation in radiation oncology
por: Krause, Mechthild
Publicado: (2013)

Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors
por: Karkare, Sharayu, et al.
Publicado: (2019)

Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing Both Kinase-Dependent and Kinase-Independent Functions of the Receptor
por: Zhang, Yuesheng
Publicado: (2023)

Functional comparison of the human epidermal growth factor receptor and telomerase reverse transcriptase promoters in canine tumor cells
por: OKAMOTO, Mariko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2ubjdktd9o44v0gvs1ck6os7dg